Pieter L. Meenhorst

2.9k total citations
51 papers, 2.3k citations indexed

About

Pieter L. Meenhorst is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Pieter L. Meenhorst has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 38 papers in Virology and 20 papers in Epidemiology. Recurrent topics in Pieter L. Meenhorst's work include HIV/AIDS drug development and treatment (40 papers), HIV Research and Treatment (38 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). Pieter L. Meenhorst is often cited by papers focused on HIV/AIDS drug development and treatment (40 papers), HIV Research and Treatment (38 papers) and Pneumocystis jirovecii pneumonia detection and treatment (13 papers). Pieter L. Meenhorst collaborates with scholars based in Netherlands, United States and Brazil. Pieter L. Meenhorst's co-authors include Jan W. Mulder, Jos H. Beijnen, Richard M. W. Hoetelmans, Joep M. A. Lange, Rolf P. G. van Heeswijk, Norbert A. Foudraine, Peter Reiss, Alwin D. R. Huitema, Monique M. R. de Maat and Agnes I. Veldkamp and has published in prestigious journals such as Annals of Internal Medicine, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Pieter L. Meenhorst

51 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pieter L. Meenhorst Netherlands	29	1.7k	1.3k	567	349	268	51	2.3k
Daniel S. Stein United States	34	1.9k 1.2×	1.3k 1.0×	1.1k 1.9×	377 1.1×	175 0.7×	92	3.0k
Rolf P. G. van Heeswijk Netherlands	24	1.9k 1.1×	750 0.6×	846 1.5×	202 0.6×	175 0.7×	41	2.3k
Mauro Sciandra Italy	26	1.0k 0.6×	707 0.5×	488 0.9×	120 0.3×	116 0.4×	53	1.7k
J. Durant France	21	1.3k 0.8×	1.1k 0.8×	380 0.7×	250 0.7×	88 0.3×	91	1.9k
Joep MA Lange Netherlands	21	1.5k 0.9×	1.4k 1.1×	809 1.4×	391 1.1×	95 0.4×	42	2.4k
Paul A. Pham United States	17	1000 0.6×	507 0.4×	457 0.8×	375 1.1×	85 0.3×	38	1.5k
Thomas N. Kakuda United States	29	2.3k 1.4×	1.5k 1.1×	889 1.6×	620 1.8×	121 0.5×	109	3.1k
Anthony J. Japour United States	23	2.8k 1.7×	2.4k 1.8×	524 0.9×	680 1.9×	72 0.3×	34	3.2k
Weerawat Manosuthi Thailand	29	1.9k 1.2×	614 0.5×	1.4k 2.5×	195 0.6×	71 0.3×	118	2.5k
Caroline Solas France	23	920 0.6×	430 0.3×	258 0.5×	171 0.5×	208 0.8×	94	1.5k

Countries citing papers authored by Pieter L. Meenhorst

Since Specialization

Citations

This map shows the geographic impact of Pieter L. Meenhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter L. Meenhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter L. Meenhorst more than expected).

Fields of papers citing papers by Pieter L. Meenhorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter L. Meenhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter L. Meenhorst. The network helps show where Pieter L. Meenhorst may publish in the future.

Co-authorship network of co-authors of Pieter L. Meenhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter L. Meenhorst. A scholar is included among the top collaborators of Pieter L. Meenhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter L. Meenhorst. Pieter L. Meenhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kappelhoff, Bregt S, Alwin D. R. Huitema, Jan M. Prins, et al.. (2005). Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals. Clinical Pharmacokinetics. 44(8). 849–861. 49 indexed citations

Smits, Paul H.M., Eefje Jong, Jan W. Mulder, et al.. (2005). High Prevalence of Human Papillomavirus Infections in Urine Samples from Human Immunodeficiency Virus-Infected Men. Journal of Clinical Microbiology. 43(12). 5936–5939. 17 indexed citations

Maat, Monique M. R. de, Alwin D. R. Huitema, Jan W. Mulder, et al.. (2003). Subtherapeutic Antiretroviral Plasma Concentrations in Routine Clinical Outpatient HIV Care. Therapeutic Drug Monitoring. 25(3). 367–373. 26 indexed citations

Maat, Monique M. R. de, Alwin D. R. Huitema, Jan W. Mulder, et al.. (2002). Population pharmacokinetics of nevirapine in an unselected cohort of HIV‐1‐infected individuals. British Journal of Clinical Pharmacology. 54(4). 378–385. 80 indexed citations

Stevens, Servi J.C., et al.. (2002). High Epstein–Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS. 16(7). 993–1001. 73 indexed citations

Maat, Monique M. R. de, Ron A. A. Mathôt, Agnes I. Veldkamp, et al.. (2002). HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS. Pharmacological Research. 46(3). 295–300. 36 indexed citations

Frankfort, Suzanne V., Ron A. A. Mathôt, Jan W. Mulder, et al.. (2002). Discrepancies between Medical and Pharmacy Records for Patients on Anti-HIV Drugs. Annals of Pharmacotherapy. 36(3). 410–415. 11 indexed citations

Heeswijk, Rolf P. G. van, Agnes I. Veldkamp, Jan W. Mulder, et al.. (2000). The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals. AIDS. 14(8). F77–F82. 113 indexed citations

Meenhorst, Pieter L., Jan W. Mulder, Gerrit Jan Weverling, et al.. (2000). Value of Different Assays for Detection of Human Cytomegalovirus (HCMV) in Predicting the Development of HCMV Disease in Human Immunodeficiency Virus-Infected Patients. Journal of Clinical Microbiology. 38(2). 563–569. 23 indexed citations

10.

Meenhorst, Pieter L., Gerrit Jan Weverling, W. Pauw, et al.. (1999). Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients. AIDS. 13(18). 2533–2539. 5 indexed citations

11.

Stuart, J. W. T. Cohen, Rob Schuurman, David M. Burger, et al.. (1999). Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study). AIDS. 13(7). F53–F58. 47 indexed citations

12.

Stevens, Servi J.C., Marcel B. H. J. Vervoort, Adriaan J. C. van den Brule, et al.. (1999). Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR. Journal of Clinical Microbiology. 37(9). 2852–2857. 99 indexed citations

13.

Foudraine, Norbert A., Gerrit Jan Weverling, Tom van Gool, et al.. (1998). Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS. 12(1). 35–41. 146 indexed citations

14.

Hoetelmans, Richard M. W., et al.. (1997). Penetration of 3'-Amino-3'-Deoxythymidine, a Cytotoxic Metabolite of Zidovudine, Into the Cerebrospinal Fluid of HIV-1-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(2). 131–136. 9 indexed citations

15.

Hoetelmans, Richard M. W., et al.. (1997). Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 698(1-2). 235–241. 48 indexed citations

16.

Hoetelmans, Richard M. W., David M. Burger, Pieter L. Meenhorst, & Jos H. Beijnen. (1996). Pharmacokinetic Individualisation of Zidovudine Therapy. Clinical Pharmacokinetics. 30(4). 314–327. 30 indexed citations

17.

Burger, David M., Pieter L. Meenhorst, Chris H.H. ten Napel, et al.. (1995). Limited sampling models for the antiretroviral agent didanosine. European Journal of Pharmaceutical Sciences. 3(1). 7–13. 1 indexed citations

18.

Burger, David M., Pieter L. Meenhorst, Jan W. Mulder, et al.. (1995). Substitution of Didanosine Sachets by Chewable Tablets. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 10(2). 163–168. 6 indexed citations

19.

Burger, David M., Pieter L. Meenhorst, Jan W. Mulder, et al.. (1993). Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV. AIDS. 7(12). 1581–1587. 55 indexed citations

20.

Meenhorst, Pieter L., et al.. (1987). The course of legionella pneumonia in guinea pigs after inhalation of various quantities of L.pneumophila. Immunobiology. 176(1-2). 108–124. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact